Literature DB >> 2458824

Histogenesis of renal cell carcinoma and renal oncocytoma. An immunohistochemical study.

C Cohen1, P A McCue, P B Derose.   

Abstract

The histogenesis of renal cell carcinoma and oncocytoma is controversial. We compared immunohistochemical profiles of normal kidney, nine carcinomas, and six oncocytomas. Carcinomas and oncocytomas expressed the following antigens respectively: proximal tubule--Uro 3 (56 & 67%), alpha-1-antitrypsin (89 & 50%); proximal and distal tubule--Uro 10 (67 & 83%); distal tubule--B2-microglobulin (100 & 100%); distal/medullary tubule--epithelial membrane antigen (89 & 83%), neuron-specific enolase (78 & 100%), glandular cytokeratin (78 & 100%), epidermal keratin (67 & 67%); and medullary tubule--Uro 8 (89 & 83%). All tumors, except one oncocytoma, had at least one positive reaction for each antigen group. Oncocytomas predominantly stained for distal/medullary tubular antigens; none showed a predominance of proximal tubular antigens. Carcinomas also demonstrated largely distal/medullary tubule antigens; 44% showed prominence of proximal tubular antigens as well. Assignment of an exclusive proximal, distal or medullary tubule origin to renal neoplasms does not appear valid. Divergent histogenesis from a precursor stem cell is likely.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458824     DOI: 10.1002/1097-0142(19881101)62:9<1946::aid-cncr2820620913>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.

Authors:  Xiang Chen; JiaXi Yao; Li Liu; WenZhong Zheng; XiaoYi Hu; YanJun Zhu; Hang Wang; JianMing Guo
Journal:  Target Oncol       Date:  2019-04       Impact factor: 4.493

2.  Renal oncocytoma. A phenotypic and genotypic entity of renal parenchymal tumors.

Authors:  G Kovacs; C Welter; L Wilkens; N Blin; W Deriese
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

Review 3.  The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting.

Authors:  Volker H Haase
Journal:  Semin Cell Dev Biol       Date:  2005-04-26       Impact factor: 7.727

4.  Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Pietschmann; H Junker; S Maile; K Schultz; C Protzel; J Giebel
Journal:  Virchows Arch       Date:  2004-08-26       Impact factor: 4.064

5.  Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis.

Authors:  Jeong Seok Hwa; Hyo Jin Park; Jae Hun Jung; Sung Chul Kam; Hyung Chul Park; Choong Won Kim; Kee Ryeon Kang; Jea Seog Hyun; Ky Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 6.  Diagnosis and prognosis of renal-cell tumors: a molecular approach.

Authors:  M Wilhelm; U Krause; G Kovacs
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

7.  Distribution of cytokeratins, vimentin and desmoplakins in normal renal tissue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy.

Authors:  A Beham; M Ratschek; K Zatloukal; C Schmid; H Denk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?

Authors:  O Yaman; S Baltaci; N Arikan; E Ozdiler; O Göğüş; Y Z Müftüoğlu
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

9.  Tumor necrosis factor in benign and malign tissue of the kidney.

Authors:  K H Bichler; S Kleinknecht; H J Nelde; W L Strohmaier
Journal:  Urol Res       Date:  1991

10.  Dysplastic ("in-situ") Lesions in multofocal renal oncocytomas (oncocytosis).

Authors:  Jiaoti Huang; Peng Lee; Yoshiki Mikami; Jonathan Melamed
Journal:  Int J Clin Exp Pathol       Date:  2009-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.